11:51 AM EST - Tekmira Pharmaceuticals Corporation : announced today that preclinical data demonstrating potent anti-viral activity of TKM-Marburg were presented at DIA/FDA Oligonucleotide-based Therapeutics Conference taking place in Washington, D.C. Tekmira Pharmaceuticals Corporation
shares T.TKM are trading up $0.40 at $7.50.
